Literature DB >> 21177839

The impact of using different symptom-based exacerbation algorithms in patients with COPD.

J C A Trappenburg1, A C van Deventer, T Troosters, T J M Verheij, A J P Schrijvers, J-W J Lammers, E M Monninkhof.   

Abstract

Not all exacerbations are captured by reliance on healthcare contacts. Symptom-based exacerbation definitions have shown to provide more adequate measures of exacerbation rates, severity and duration. However, no consensus has been reached on what is the most useful method and algorithm to identify these events. This article provides an overview of the existing symptom-based definitions and tests the hypothesis that differences in exacerbation characteristics depend on the algorithms used. We systematically reviewed symptom-based methods and algorithms used in the literature, and quantified the impact of the four most referenced algorithms on exacerbation-related outcome using an existing chronic obstructive pulmonary disease (COPD) cohort (n = 137). We identified 51 studies meeting our criteria using 14 widely varying symptom algorithms to define onset, severity and recovery. The most (71%) frequently referenced algorithm (modified Anthonisen) identified an incidence rate of 1.7 episodes·patient-yr⁻¹ (95% CI 1.4-2.1), while for requiring only one major or two major symptoms this was 1.9 episodes·patient-yr⁻¹ (95% CI 1.6-2.3) and 1.5 episodes·patient-yr⁻¹ (95% CI 0.6-1.0), respectively. Studies were generally lacking methods to enhance validity and accuracy of symptom recording. This review revealed large inconsistencies in definitions, methods and accuracy to define symptom-based COPD exacerbations. We demonstrated that minor changes in symptom criteria substantially affect incidence rates, clustering type and classification of exacerbations.

Entities:  

Mesh:

Year:  2010        PMID: 21177839     DOI: 10.1183/09031936.00130910

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

1.  Preventing COPD exacerbations: new options for a crucial and growing problem.

Authors:  Jeffrey L Curtis; Carlos H Martinez
Journal:  Fed Pract       Date:  2014-03

2.  Putting health status guided COPD management to the test: protocol of the MARCH study.

Authors:  Janwillem Kocks; Corina de Jong; Marjolein Y Berger; Huib A M Kerstjens; Thys van der Molen
Journal:  BMC Pulm Med       Date:  2013-07-04       Impact factor: 3.317

3.  Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation.

Authors:  Rebecca DeVries; David Kriebel; Susan Sama
Journal:  NPJ Prim Care Respir Med       Date:  2016-12-01       Impact factor: 2.871

4.  Neural Respiratory Drive Measured Using Surface Electromyography of Diaphragm as a Physiological Biomarker to Predict Hospitalization of Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients.

Authors:  Dan-Dan Zhang; Gan Lu; Xuan-Feng Zhu; Ling-Ling Zhang; Jia Gao; Li-Cheng Shi; Jian-Hua Gu; Jian-Nan Liu
Journal:  Chin Med J (Engl)       Date:  2018-12-05       Impact factor: 2.628

Review 5.  Self management for patients with chronic obstructive pulmonary disease.

Authors:  Marlies Zwerink; Marjolein Brusse-Keizer; Paul D L P M van der Valk; Gerhard A Zielhuis; Evelyn M Monninkhof; Job van der Palen; Peter A Frith; Tanja Effing
Journal:  Cochrane Database Syst Rev       Date:  2014-03-19

6.  Primary care physician perceptions on the diagnosis and management of chronic obstructive pulmonary disease in diverse regions of the world.

Authors:  Zaurbek Aisanov; Chunxue Bai; Otto Bauerle; Federico D Colodenco; Charles Feldman; Shu Hashimoto; Jose Jardim; Christopher K W Lai; Rafael Laniado-Laborin; Gilbert Nadeau; Abdullah Sayiner; Jae Jeong Shim; Ying Huang Tsai; Richard D Walters; Grant Waterer
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-04-05

7.  Do self-management interventions in COPD patients work and which patients benefit most? An individual patient data meta-analysis.

Authors:  Nini H Jonkman; Heleen Westland; Jaap Ca Trappenburg; Rolf Hh Groenwold; Erik Wma Bischoff; Jean Bourbeau; Christine E Bucknall; David Coultas; Tanja W Effing; Michael J Epton; Frode Gallefoss; Judith Garcia-Aymerich; Suzanne M Lloyd; Evelyn M Monninkhof; Huong Q Nguyen; Job van der Palen; Kathryn L Rice; Maria Sedeno; Stephanie Jc Taylor; Thierry Troosters; Nicholas A Zwar; Arno W Hoes; Marieke J Schuurmans
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-08-31

8.  'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.

Authors:  L M Boer; E W Bischoff; X Borgijink; J H Vercoulen; R P Akkermans; H A M Kerstjens; W J Assendelft; T R Schermer
Journal:  NPJ Prim Care Respir Med       Date:  2018-04-03       Impact factor: 2.871

9.  Association between COPD exacerbations and lung function decline during maintenance therapy.

Authors:  Marjan Kerkhof; Jaco Voorham; Paul Dorinsky; Claudia Cabrera; Patrick Darken; Janwillem Wh Kocks; Mohsen Sadatsafavi; Don D Sin; Victoria Carter; David B Price
Journal:  Thorax       Date:  2020-06-12       Impact factor: 9.139

10.  Overtreatment of COPD with inhaled corticosteroids--implications for safety and costs: cross-sectional observational study.

Authors:  Patrick White; Hannah Thornton; Hilary Pinnock; Sofia Georgopoulou; Helen P Booth
Journal:  PLoS One       Date:  2013-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.